AstraZeneca Hits Another Bump in the Road to COVID-19 Vaccine Approval in the US

AstraZeneca’s COVID-19 vaccine road to approval has been anything but smooth. Announcing in March a mid-April submission for U.S. approval, that timeline has been pushed back to mid-May, with the company citing the massive dataset as the cause.